Skip to main content

D. E. Shaw & Co., Inc.

Position in FLNA — Filana Therapeutics, Inc.

CIK 1009207 New York, NY

Position in FLNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$945,056
+$15,792 QoQ
Shares Held
559,205
+19.2% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Derivatives in FLNA

reported options exposure · as of Dec 31, 2022
CallValue
$295,400
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,382,181,502 across 180 Biotechnology names. FLNA ranks #143 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLNA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $945,056 559,205
2025-12-31 $929,264 469,326
2023-09-30 $275,441 16,553
2023-06-30 $322,094 13,136
2022-12-31 $295,400 10,000
2022-09-30 $418,200 10,000
2022-06-30 $281,200 10,000
2022-03-31 $371,400 10,000
2022-03-31 $1,649,016 44,400
2021-12-31 $437,000 10,000
2021-09-30 $620,800 10,000
2021-09-30 $3,058,619 49,269
2021-06-30 $5,125,545 59,990
2021-06-30 $854,400 10,000